Alzheimer’s Slowed by Stem Cells From Umbilical Cord Blood
More than 5 million people in the U.S. alone are currently afflicted with Alzheimer’s disease, and the global number is…
View Article
Blog Articles
Explore our articles
Phase III Clinical Trials Begin With Cord Blood Stem Cells in the Treatment of Metabolic Disorders in Pediatric Patients
Aldagen, Inc., a biopharmaceutical company specializing in the development of proprietary regenerative cell therapies, reports the commencement of Phase III…
View ArticleAdult Stem Cells Show Positive Results in a Pre-Clinical Study of Multiple Sclerosis
Pluristem Therapeutics Inc., which specializes in the commercialization of therapeutic products developed exclusively from adult mesenchymal stromal cells (MSCs) that…
View ArticleCautionary Response Issued for Clinical Trials With Embryonic Stem Cells
Three biotech companies are currently preparing for their upcoming clinical trials that will test the therapeutic value of their proprietary…
View ArticleAn Adult Stem Cell Bill Advances in the Colorado State Legislature
Currently in the state of Colorado, there are only three hospitals in which the systematic collection of umbilical cord blood…
View ArticleMesenchymal Stem Cells Discovered in the Eye
Mesenchymal stem cells (MSCs) are recognized as one of the most important types of stem cells, with one of the…
View ArticleDisease Susceptibility Traced to Specific Genes in Human Embryonic Stem Cells
Embryonic stem cells are known to carry a number of risks, not the least of which is genetic mutation which…
View Article